Answers are grounded in this paper and cite their sources.
Systematic review assesses how ramadan fasting influences inflammation in overweight and non-obese people, suggesting potential health benefits.
Introduction: Ramadan fasting (RF) has been suggested to modulate inflammation. Inflammatory biomarkers such as interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and C-reactive protein (CRP) play pivotal roles in various metabolic and immune-related diseases. Given their clinical relevance, this study aims to evaluate the impact of RF on IL-6, TNF-α, and CRP. Methods: A systematic search of the literature evaluating the impact of RF on IL-6, TNF-α, and CRP/high sensitivity CRP (hsCRP) published in PubMed, ScienceDirect, Scopus, and Google Scholar was employed. Study quality was evaluated using the Newcastle-Ottawa Scale. Fixed- or random-effects model meta-analyses were performed using RevMan version 5.4 software. Subgroup analysis was performed based on BMI status, in overweight and/or obese (BMI ≥25) and non-obese (BMI ≥18.5) individuals. Meta-analysis was presented in standardized mean difference (SMD) with 95% confidence interval (CI). Fourteen studies involving 522 participants were finally included. Results: The finding showed that RF significantly reduced IL-6 (SMD = 0.68; 95% CI = 0.50, 0.87; p <0.00001) and TNF-α (SMD = 0.69; 95% CI = 0.34, 1.04; p = 0.0001), with stronger effects in overweight and/or obese individuals for IL-6 (SMD = 0.71; 95% CI = 0.52, 0.90; p <0.00001) and TNF-α (SMD = 0.79; 95% CI = 0.35, 1.23; p = 0.0005). Meanwhile, the reduction of CRP/hsCRP was significant only in non-obese individuals (SMD = 1.03; 95% CI = 0.04, 2.02; p = 0.04). Conclusion: RF may serve as a natural strategy to reduce systemic inflammation, particularly in individuals with elevated BMI. These findings may have clinical relevance for populations at risk of inflammation-related conditions such as obesity and metabolic syndrome. However, the heterogeneity in this meta-analysis requires the interpretation of the results with caution.
No takes yet. Share an insight, caveat, or question.
Ridho et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: